Elekta Unity MR-linac featured in 11 abstracts at ASTRO 2018
Diverse studies demonstrate transformative potential for MR/RT in various cancer indications to deliver radiation to a variety of tumor types while protecting nearby tissues and organsSTOCKHOLM, November 1, 2018 – Elekta (EKTA-B.ST) today announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system was featured in 11 abstracts at the American Society for Radiation Oncology (ASTRO) Annual Meeting, which took place October 21-24 in San Antonio, Texas. Elekta Unity, which received CE Mark in June 2018 and currently pending U.S. FDA 510(k) premarket clearance, is the